Clinical Trial Update: To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating multiple dose and concentration regimens of Qwo for mild to moderate cellulite has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulite

Drugs mentioned

• QWO (collagenase clostridium histolyticum-aaes)

Snippet

Sponsor: DMR Research, PLLC | Conditions: Cellulite | Phase 4 | Status: COMPLETED